Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000350422

Medchemexpress LLC AMG 837 calcium hydrate | 1259389-38-2 | 99.0% | 455.45 | 1 ML
SDP

Catalog No. 5000350422
Encompass_Preferred

AMG 837 calcium hydrate is a potent, orally bioavailable, and partial agonist of GPR40/FFA1. It inhibits specific binding at the human FFA1 receptor with a pIC50 of 8.13. This compound can enhance insulin secretion and lower glucose levels in rodents.

  • Stimulates insulin secretion in a glucose-dependent manner.
  • Stimulates Ca2+ flux in human, mouse, and rat receptors.
  • Reduces glucose levels and increases insulin levels in vivo.
  • Improves glucose tolerance and enhances insulin secretion.
  • Displays excellent oral bioavailability.
  • Click chemistry reagent containing an alkyne group.

Catalog No. 50-003-50422 Supplier Medchemexpress LLC Supplier No. HY13967B10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AMG 837 calcium hydrate is a potent, orally bioavailable, and partial agonist of GPR40/FFA1. It inhibits specific binding at the human FFA1 receptor with a pIC50 of 8.13. This compound can enhance insulin secretion and lower glucose levels in rodents.

  • Stimulates insulin secretion in a glucose-dependent manner.
  • Stimulates Ca2+ flux in human, mouse, and rat receptors.
  • Reduces glucose levels and increases insulin levels in vivo.
  • Improves glucose tolerance and enhances insulin secretion.
  • Displays excellent oral bioavailability.
  • Click chemistry reagent containing an alkyne group.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.